Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationTransplantation, AutologousGraft vs Host DiseaseTransplantation ConditioningBone Marrow TransplantationStem CellsPeripheral Blood Stem Cell TransplantationHematologic NeoplasmsTissue DonorsGraft SurvivalTreatment OutcomeHistocompatibility TestingKidney TransplantationBusulfanGraft vs Tumor EffectRecurrenceLiver TransplantationWhole-Body IrradiationTransplantation ChimeraLeukemiaHematopoietic Stem CellsRemission InductionRetrospective StudiesCombined Modality TherapyCord Blood Stem Cell TransplantationMesenchymal Stem Cell TransplantationImmunosuppressive AgentsCell TransplantationMyeloablative AgonistsSurvival AnalysisGraft RejectionLeukemia, Myeloid, AcuteTime FactorsDisease-Free SurvivalEmbryonic Stem CellsHeart TransplantationSurvival RateHistocompatibilityAdult Stem CellsMultiple MyelomaGranulocyte Colony-Stimulating FactorGraft vs Leukemia EffectLung TransplantationTransplantation ImmunologyMelphalanHematopoietic Stem Cell MobilizationTransplantationTransplantation, IsogeneicVidarabineCell DifferentiationImmunosuppressionPluripotent Stem CellsCyclophosphamideHLA AntigensHepatic Veno-Occlusive DiseaseChimerismAntigens, CD34Antineoplastic Combined Chemotherapy ProtocolsCytomegalovirus InfectionsSalvage TherapyNeural Stem CellsStem Cell NicheMesenchymal Stromal CellsFollow-Up StudiesHematologic DiseasesSiblingsMyelodysplastic SyndromesIslets of Langerhans TransplantationAntilymphocyte SerumT-LymphocytesCyclosporineLiving DonorsLymphocyte DepletionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantsOrgan TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaInduced Pluripotent Stem CellsLymphoma, Non-HodgkinAcute DiseaseAnemia, AplasticLymphocyte TransfusionBone Marrow CellsTransplantation ToleranceCells, CulturedMultipotent Stem CellsPrognosisHematopoiesisMice, Inbred C57BLFlow CytometryCytarabineImmunocompromised HostUnrelated DonorsHodgkin DiseaseCell LineageTacrolimusInfectionFetal Tissue Transplantation